What is 'Brazilian Health Surveillance Agency' in SAP IS-PHA-ATT - SAP Advanced Track and Trace for Pharmaceuticals?

Brazilian Health Surveillance Agency - Overview

• Component: IS-PHA-ATT

• Component Name: SAP Advanced Track and Trace for Pharmaceuticals

• Description: A regulatory body of the Brazilian government. The agency is responsible for the regulation and approval of pharmaceutical drugs, sanitary standards, and regulation of the food industry.

Brazilian Health Surveillance Agency - Details

• 
  Key Concepts:
  The Brazilian Health Surveillance Agency (ANVISA) is a government agency responsible for regulating the production, distribution, and sale of pharmaceuticals in Brazil. The IS-PHA-ATT SAP Advanced Track and Trace for Pharmaceuticals component is a software solution designed to help companies comply with ANVISA regulations. It provides an end-to-end traceability system that tracks the movement of pharmaceuticals from production to sale.
  
  How to use it:
  The IS-PHA-ATT SAP Advanced Track and Trace for Pharmaceuticals component can be used to track the movement of pharmaceuticals from production to sale. It provides a comprehensive view of the entire supply chain, including product information, serial numbers, and expiration dates. It also allows companies to monitor their inventory levels and ensure compliance with ANVISA regulations.
  
  Tips & Tricks:
  When using the IS-PHA-ATT SAP Advanced Track and Trace for Pharmaceuticals component, it is important to ensure that all data is accurate and up-to-date. This will help ensure compliance with ANVISA regulations and reduce the risk of errors or delays in the supply chain. Additionally, it is important to regularly review the system to ensure that all data is accurate and up-to-date.
  
  Related Information:
  The IS-PHA-ATT SAP Advanced Track and Trace for Pharmaceuticals component is part of the SAP Pharma Suite, which provides a comprehensive set of solutions for managing pharmaceutical supply chains. Additionally, ANVISA has published guidelines on how companies should comply with its regulations, which